UNSPSC 51142428: Ergotamine tartrate

This classification denotes a serotonin agonist and alpha-adrenergic agonist with the molecular formula 2C33H35N5O5.C4H6O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MRU5XH3B48, chemically known as ergotamine, tartrate (2:1) (salt) (8ci) but more generally known as ergotamine tartrate, which bears US NIH Compound Identifier 9787. European Medicines Agency schedules Ergotamine tartrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01934MIG.

UNSPSC 51142428 Ergotamine tartrate is a Commodity code that shows significant misalignment between its nominal scope and recent state and local procurement activity. The three recent opportunities posted under this code involve naloxone distribution, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals—none of which center on ergotamine tartrate specifically. State and local issuers posting under this code are soliciting broader pharmaceutical and health-system products through health departments, state HHS commissions, and multistate cooperative purchasing alliances rather than targeting ergotamine tartrate as a distinct commodity.

Activity spans Florida (Seminole County), Texas (HHS Commission), and Minnesota (MMCAP cooperative purchasing serving multiple states including Oregon), with the most recent and concrete opportunity being Seminole County's IFB60459723LAS, posted June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a July 26, 2023 response deadline and quarterly deliveries to the County Community Health Building in Sanford, Florida. The Texas HHS Commission issued an RFI (HHS0017013) on April 3, 2026 to gather market intelligence on direct-to-manufacturer prescription programs, and MMCAP posted an RFP (S1070000015802) on January 20, 2026 for generic multi-source pharmaceuticals and OTC products with a March 26, 2026 response deadline and July 1, 2026 contract effective date. The code shows limited genuine relevance to ergotamine tartrate procurement; vendors targeting this specific commodity should verify that state and local issuing bodies have properly classified their opportunities or consider whether broader pharmaceutical supply relationships align with business objectives.